Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Cannabis Testing Services Market

ID: MRFR/HS/19927-HCR
128 Pages
Nidhi Mandole
Last Updated: April 06, 2026

Cannabis Testing Services Market Research Report Information By Type (Potency Testing, Terpene Profiling, Heavy Metal Testing, Pesticide Screening, Microscopy Testing, Residual Solvent Screening, Others), By End Use (Cannabis Drug Manufacturers, Cannabis Cultivators/Growers, Others (Research Institutes & Labs)) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Cannabis Testing Services Market Infographic
Purchase Options
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Healthcare, BY Type (USD Billion)
  49.     4.1.1 Potency Testing
  50.     4.1.2 Terpene Profiling
  51.     4.1.3 Heavy Metal Testing
  52.     4.1.4 Pesticide Screening
  53.     4.1.5 Microscopy Testing
  54.     4.1.6 Residual Solvent Screening
  55.     4.1.7 Others
  56.   4.2 Healthcare, BY End Use (USD Billion)
  57.     4.2.1 Cannabis Drug Manufacturers
  58.     4.2.2 Cannabis Cultivators/Growers
  59.     4.2.3 Others (Research Institutes & Labs)
  60.   4.3 Healthcare, BY Region (USD Billion)
  61.     4.3.1 North America
  62.       4.3.1.1 US
  63.       4.3.1.2 Canada
  64.     4.3.2 Europe
  65.       4.3.2.1 Germany
  66.       4.3.2.2 UK
  67.       4.3.2.3 France
  68.       4.3.2.4 Russia
  69.       4.3.2.5 Italy
  70.       4.3.2.6 Spain
  71.       4.3.2.7 Rest of Europe
  72.     4.3.3 APAC
  73.       4.3.3.1 China
  74.       4.3.3.2 India
  75.       4.3.3.3 Japan
  76.       4.3.3.4 South Korea
  77.       4.3.3.5 Malaysia
  78.       4.3.3.6 Thailand
  79.       4.3.3.7 Indonesia
  80.       4.3.3.8 Rest of APAC
  81.     4.3.4 South America
  82.       4.3.4.1 Brazil
  83.       4.3.4.2 Mexico
  84.       4.3.4.3 Argentina
  85.       4.3.4.4 Rest of South America
  86.     4.3.5 MEA
  87.       4.3.5.1 GCC Countries
  88.       4.3.5.2 South Africa
  89.       4.3.5.3 Rest of MEA
  90. 5 SECTION V: COMPETITIVE ANALYSIS
  91.   5.1 Competitive Landscape
  92.     5.1.1 Overview
  93.     5.1.2 Competitive Analysis
  94.     5.1.3 Market share Analysis
  95.     5.1.4 Major Growth Strategy in the Healthcare
  96.     5.1.5 Competitive Benchmarking
  97.     5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  98.     5.1.7 Key developments and growth strategies
  99.       5.1.7.1 New Product Launch/Service Deployment
  100.       5.1.7.2 Merger & Acquisitions
  101.       5.1.7.3 Joint Ventures
  102.     5.1.8 Major Players Financial Matrix
  103.       5.1.8.1 Sales and Operating Income
  104.       5.1.8.2 Major Players R&D Expenditure. 2023
  105.   5.2 Company Profiles
  106.     5.2.1 Steep Hill (US)
  107.       5.2.1.1 Financial Overview
  108.       5.2.1.2 Products Offered
  109.       5.2.1.3 Key Developments
  110.       5.2.1.4 SWOT Analysis
  111.       5.2.1.5 Key Strategies
  112.     5.2.2 SC Labs (US)
  113.       5.2.2.1 Financial Overview
  114.       5.2.2.2 Products Offered
  115.       5.2.2.3 Key Developments
  116.       5.2.2.4 SWOT Analysis
  117.       5.2.2.5 Key Strategies
  118.     5.2.3 Eurofins Scientific (FR)
  119.       5.2.3.1 Financial Overview
  120.       5.2.3.2 Products Offered
  121.       5.2.3.3 Key Developments
  122.       5.2.3.4 SWOT Analysis
  123.       5.2.3.5 Key Strategies
  124.     5.2.4 Bureau Veritas (FR)
  125.       5.2.4.1 Financial Overview
  126.       5.2.4.2 Products Offered
  127.       5.2.4.3 Key Developments
  128.       5.2.4.4 SWOT Analysis
  129.       5.2.4.5 Key Strategies
  130.     5.2.5 MCR Labs (US)
  131.       5.2.5.1 Financial Overview
  132.       5.2.5.2 Products Offered
  133.       5.2.5.3 Key Developments
  134.       5.2.5.4 SWOT Analysis
  135.       5.2.5.5 Key Strategies
  136.     5.2.6 CannaSafe (US)
  137.       5.2.6.1 Financial Overview
  138.       5.2.6.2 Products Offered
  139.       5.2.6.3 Key Developments
  140.       5.2.6.4 SWOT Analysis
  141.       5.2.6.5 Key Strategies
  142.     5.2.7 Green Leaf Lab (US)
  143.       5.2.7.1 Financial Overview
  144.       5.2.7.2 Products Offered
  145.       5.2.7.3 Key Developments
  146.       5.2.7.4 SWOT Analysis
  147.       5.2.7.5 Key Strategies
  148.     5.2.8 ProVerde Laboratories (US)
  149.       5.2.8.1 Financial Overview
  150.       5.2.8.2 Products Offered
  151.       5.2.8.3 Key Developments
  152.       5.2.8.4 SWOT Analysis
  153.       5.2.8.5 Key Strategies
  154.     5.2.9 Psychemedics Corporation (US)
  155.       5.2.9.1 Financial Overview
  156.       5.2.9.2 Products Offered
  157.       5.2.9.3 Key Developments
  158.       5.2.9.4 SWOT Analysis
  159.       5.2.9.5 Key Strategies
  160.   5.3 Appendix
  161.     5.3.1 References
  162.     5.3.2 Related Reports
  163. 6 LIST OF FIGURES
  164.   6.1 MARKET SYNOPSIS
  165.   6.2 NORTH AMERICA MARKET ANALYSIS
  166.   6.3 US MARKET ANALYSIS BY TYPE
  167.   6.4 US MARKET ANALYSIS BY END USE
  168.   6.5 CANADA MARKET ANALYSIS BY TYPE
  169.   6.6 CANADA MARKET ANALYSIS BY END USE
  170.   6.7 EUROPE MARKET ANALYSIS
  171.   6.8 GERMANY MARKET ANALYSIS BY TYPE
  172.   6.9 GERMANY MARKET ANALYSIS BY END USE
  173.   6.10 UK MARKET ANALYSIS BY TYPE
  174.   6.11 UK MARKET ANALYSIS BY END USE
  175.   6.12 FRANCE MARKET ANALYSIS BY TYPE
  176.   6.13 FRANCE MARKET ANALYSIS BY END USE
  177.   6.14 RUSSIA MARKET ANALYSIS BY TYPE
  178.   6.15 RUSSIA MARKET ANALYSIS BY END USE
  179.   6.16 ITALY MARKET ANALYSIS BY TYPE
  180.   6.17 ITALY MARKET ANALYSIS BY END USE
  181.   6.18 SPAIN MARKET ANALYSIS BY TYPE
  182.   6.19 SPAIN MARKET ANALYSIS BY END USE
  183.   6.20 REST OF EUROPE MARKET ANALYSIS BY TYPE
  184.   6.21 REST OF EUROPE MARKET ANALYSIS BY END USE
  185.   6.22 APAC MARKET ANALYSIS
  186.   6.23 CHINA MARKET ANALYSIS BY TYPE
  187.   6.24 CHINA MARKET ANALYSIS BY END USE
  188.   6.25 INDIA MARKET ANALYSIS BY TYPE
  189.   6.26 INDIA MARKET ANALYSIS BY END USE
  190.   6.27 JAPAN MARKET ANALYSIS BY TYPE
  191.   6.28 JAPAN MARKET ANALYSIS BY END USE
  192.   6.29 SOUTH KOREA MARKET ANALYSIS BY TYPE
  193.   6.30 SOUTH KOREA MARKET ANALYSIS BY END USE
  194.   6.31 MALAYSIA MARKET ANALYSIS BY TYPE
  195.   6.32 MALAYSIA MARKET ANALYSIS BY END USE
  196.   6.33 THAILAND MARKET ANALYSIS BY TYPE
  197.   6.34 THAILAND MARKET ANALYSIS BY END USE
  198.   6.35 INDONESIA MARKET ANALYSIS BY TYPE
  199.   6.36 INDONESIA MARKET ANALYSIS BY END USE
  200.   6.37 REST OF APAC MARKET ANALYSIS BY TYPE
  201.   6.38 REST OF APAC MARKET ANALYSIS BY END USE
  202.   6.39 SOUTH AMERICA MARKET ANALYSIS
  203.   6.40 BRAZIL MARKET ANALYSIS BY TYPE
  204.   6.41 BRAZIL MARKET ANALYSIS BY END USE
  205.   6.42 MEXICO MARKET ANALYSIS BY TYPE
  206.   6.43 MEXICO MARKET ANALYSIS BY END USE
  207.   6.44 ARGENTINA MARKET ANALYSIS BY TYPE
  208.   6.45 ARGENTINA MARKET ANALYSIS BY END USE
  209.   6.46 REST OF SOUTH AMERICA MARKET ANALYSIS BY TYPE
  210.   6.47 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USE
  211.   6.48 MEA MARKET ANALYSIS
  212.   6.49 GCC COUNTRIES MARKET ANALYSIS BY TYPE
  213.   6.50 GCC COUNTRIES MARKET ANALYSIS BY END USE
  214.   6.51 SOUTH AFRICA MARKET ANALYSIS BY TYPE
  215.   6.52 SOUTH AFRICA MARKET ANALYSIS BY END USE
  216.   6.53 REST OF MEA MARKET ANALYSIS BY TYPE
  217.   6.54 REST OF MEA MARKET ANALYSIS BY END USE
  218.   6.55 KEY BUYING CRITERIA OF HEALTHCARE
  219.   6.56 RESEARCH PROCESS OF MRFR
  220.   6.57 DRO ANALYSIS OF HEALTHCARE
  221.   6.58 DRIVERS IMPACT ANALYSIS: HEALTHCARE
  222.   6.59 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
  223.   6.60 SUPPLY / VALUE CHAIN: HEALTHCARE
  224.   6.61 HEALTHCARE, BY TYPE, 2024 (% SHARE)
  225.   6.62 HEALTHCARE, BY TYPE, 2024 TO 2035 (USD Billion)
  226.   6.63 HEALTHCARE, BY END USE, 2024 (% SHARE)
  227.   6.64 HEALTHCARE, BY END USE, 2024 TO 2035 (USD Billion)
  228.   6.65 BENCHMARKING OF MAJOR COMPETITORS
  229. 7 LIST OF TABLES
  230.   7.1 LIST OF ASSUMPTIONS
  231.     7.1.1
  232.   7.2 North America MARKET SIZE ESTIMATES; FORECAST
  233.     7.2.1 BY TYPE, 2025-2035 (USD Billion)
  234.     7.2.2 BY END USE, 2025-2035 (USD Billion)
  235.   7.3 US MARKET SIZE ESTIMATES; FORECAST
  236.     7.3.1 BY TYPE, 2025-2035 (USD Billion)
  237.     7.3.2 BY END USE, 2025-2035 (USD Billion)
  238.   7.4 Canada MARKET SIZE ESTIMATES; FORECAST
  239.     7.4.1 BY TYPE, 2025-2035 (USD Billion)
  240.     7.4.2 BY END USE, 2025-2035 (USD Billion)
  241.   7.5 Europe MARKET SIZE ESTIMATES; FORECAST
  242.     7.5.1 BY TYPE, 2025-2035 (USD Billion)
  243.     7.5.2 BY END USE, 2025-2035 (USD Billion)
  244.   7.6 Germany MARKET SIZE ESTIMATES; FORECAST
  245.     7.6.1 BY TYPE, 2025-2035 (USD Billion)
  246.     7.6.2 BY END USE, 2025-2035 (USD Billion)
  247.   7.7 UK MARKET SIZE ESTIMATES; FORECAST
  248.     7.7.1 BY TYPE, 2025-2035 (USD Billion)
  249.     7.7.2 BY END USE, 2025-2035 (USD Billion)
  250.   7.8 France MARKET SIZE ESTIMATES; FORECAST
  251.     7.8.1 BY TYPE, 2025-2035 (USD Billion)
  252.     7.8.2 BY END USE, 2025-2035 (USD Billion)
  253.   7.9 Russia MARKET SIZE ESTIMATES; FORECAST
  254.     7.9.1 BY TYPE, 2025-2035 (USD Billion)
  255.     7.9.2 BY END USE, 2025-2035 (USD Billion)
  256.   7.10 Italy MARKET SIZE ESTIMATES; FORECAST
  257.     7.10.1 BY TYPE, 2025-2035 (USD Billion)
  258.     7.10.2 BY END USE, 2025-2035 (USD Billion)
  259.   7.11 Spain MARKET SIZE ESTIMATES; FORECAST
  260.     7.11.1 BY TYPE, 2025-2035 (USD Billion)
  261.     7.11.2 BY END USE, 2025-2035 (USD Billion)
  262.   7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
  263.     7.12.1 BY TYPE, 2025-2035 (USD Billion)
  264.     7.12.2 BY END USE, 2025-2035 (USD Billion)
  265.   7.13 APAC MARKET SIZE ESTIMATES; FORECAST
  266.     7.13.1 BY TYPE, 2025-2035 (USD Billion)
  267.     7.13.2 BY END USE, 2025-2035 (USD Billion)
  268.   7.14 China MARKET SIZE ESTIMATES; FORECAST
  269.     7.14.1 BY TYPE, 2025-2035 (USD Billion)
  270.     7.14.2 BY END USE, 2025-2035 (USD Billion)
  271.   7.15 India MARKET SIZE ESTIMATES; FORECAST
  272.     7.15.1 BY TYPE, 2025-2035 (USD Billion)
  273.     7.15.2 BY END USE, 2025-2035 (USD Billion)
  274.   7.16 Japan MARKET SIZE ESTIMATES; FORECAST
  275.     7.16.1 BY TYPE, 2025-2035 (USD Billion)
  276.     7.16.2 BY END USE, 2025-2035 (USD Billion)
  277.   7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
  278.     7.17.1 BY TYPE, 2025-2035 (USD Billion)
  279.     7.17.2 BY END USE, 2025-2035 (USD Billion)
  280.   7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
  281.     7.18.1 BY TYPE, 2025-2035 (USD Billion)
  282.     7.18.2 BY END USE, 2025-2035 (USD Billion)
  283.   7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
  284.     7.19.1 BY TYPE, 2025-2035 (USD Billion)
  285.     7.19.2 BY END USE, 2025-2035 (USD Billion)
  286.   7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
  287.     7.20.1 BY TYPE, 2025-2035 (USD Billion)
  288.     7.20.2 BY END USE, 2025-2035 (USD Billion)
  289.   7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
  290.     7.21.1 BY TYPE, 2025-2035 (USD Billion)
  291.     7.21.2 BY END USE, 2025-2035 (USD Billion)
  292.   7.22 South America MARKET SIZE ESTIMATES; FORECAST
  293.     7.22.1 BY TYPE, 2025-2035 (USD Billion)
  294.     7.22.2 BY END USE, 2025-2035 (USD Billion)
  295.   7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
  296.     7.23.1 BY TYPE, 2025-2035 (USD Billion)
  297.     7.23.2 BY END USE, 2025-2035 (USD Billion)
  298.   7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
  299.     7.24.1 BY TYPE, 2025-2035 (USD Billion)
  300.     7.24.2 BY END USE, 2025-2035 (USD Billion)
  301.   7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
  302.     7.25.1 BY TYPE, 2025-2035 (USD Billion)
  303.     7.25.2 BY END USE, 2025-2035 (USD Billion)
  304.   7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
  305.     7.26.1 BY TYPE, 2025-2035 (USD Billion)
  306.     7.26.2 BY END USE, 2025-2035 (USD Billion)
  307.   7.27 MEA MARKET SIZE ESTIMATES; FORECAST
  308.     7.27.1 BY TYPE, 2025-2035 (USD Billion)
  309.     7.27.2 BY END USE, 2025-2035 (USD Billion)
  310.   7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
  311.     7.28.1 BY TYPE, 2025-2035 (USD Billion)
  312.     7.28.2 BY END USE, 2025-2035 (USD Billion)
  313.   7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
  314.     7.29.1 BY TYPE, 2025-2035 (USD Billion)
  315.     7.29.2 BY END USE, 2025-2035 (USD Billion)
  316.   7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
  317.     7.30.1 BY TYPE, 2025-2035 (USD Billion)
  318.     7.30.2 BY END USE, 2025-2035 (USD Billion)
  319.   7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  320.     7.31.1
  321.   7.32 ACQUISITION/PARTNERSHIP
  322.     7.32.1

Healthcare Market Segmentation

Healthcare By Type (USD Billion, 2025-2035)

  • Potency Testing
  • Terpene Profiling
  • Heavy Metal Testing
  • Pesticide Screening
  • Microscopy Testing
  • Residual Solvent Screening
  • Others

Healthcare By End Use (USD Billion, 2025-2035)

  • Cannabis Drug Manufacturers
  • Cannabis Cultivators/Growers
  • Others (Research Institutes & Labs)

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions